Cancer has long been medicine’s most elusive target, but a wave of new research suggests scientists may finally be closing in ...

NASHVILLE Tenn. (WKRN) — It can take more than a decade to develop a new vaccine for children. After years of research and testing, some don’t pass the safety checks. One laboratory at Vanderbilt ...

Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...

Vaccine hesitancy isn’t a moral failure – it’s a property of a system in which people must balance personal and collective ...

An initiative born at Rutgers University is taking a shot at building vaccine confidence. Founded in March 2023 while longtime Johnson & Johnson executive Hajar Shirley was working on her doctorate, ...

Public health experts say Europeans can afford to vaccinate less because they have universal access to health care.

RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...